Your browser doesn't support javascript.
Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2.
Cortés-Borra, Albert; Aranda-Abreu, Gonzalo Emiliano.
  • Cortés-Borra A; Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Aranda-Abreu GE; Universidad Veracruzana/Instituto de Investigaciones Cerebrales, Xalapa, Veracruz, Mexico. garanda@uv.mx.
Pharmacol Rep ; 73(3): 962-965, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1091991
ABSTRACT

BACKGROUND:

Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies.

METHODS:

We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson's disease.

RESULTS:

Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus.

CONCLUSION:

Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Amantadine / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study / Reviews Limits: Humans Language: English Journal: Pharmacol Rep Journal subject: Pharmacology Year: 2021 Document Type: Article Affiliation country: S43440-021-00231-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Amantadine / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study / Reviews Limits: Humans Language: English Journal: Pharmacol Rep Journal subject: Pharmacology Year: 2021 Document Type: Article Affiliation country: S43440-021-00231-5